Situation + Complication
As you know, our expert interviews are focused on determining how your presence in this domain should play a part in your long-term strategy.
However, early takeaways indicate that potential AI disruption in the field is creating inconsistency among experts about the long-term value of this technology.
As you know, our research and evaluation have identified several organizations that would be viable acquisition targets.
However, the most attractive options require greater resources than you’ve deemed feasible.
As you know, we've been focusing our primary research program on these types of clinicians across three geographies.
However, we are experiencing challenges fielding sufficient input from one of the geographies, limiting our ability to assess that market's feasibility.
As you know, we’re designing a complex survey intended to capture broad expert insights within a 10-day fielding window.
However, with the request to move the final deliverable up by a week, the compressed timeline creates pressure on survey development, testing, and fielding.
As you know, in Phase 1 of this project, we've been narrowing over 900 target indications to a list of just 30 to evaluate more deeply in Phase 2.
However, the agreed upon criteria for prioritization is not yielding significant enough differentiation, and in our last check-in, we heard opposing views from members of leadership on where to focus.